Get the Stockscreener App
147.44
0.84%
1.23
After Hours:
147.44
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $147.44, with a volume of 699.19K.
It is up +0.84% in the last 24 hours and down -1.79% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$146.21
Open:
$145.51
24h Volume:
699.19K
Relative Volume:
1.06
Market Cap:
$8.01B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-15.99
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
+0.17%
1M Performance:
-1.79%
6M Performance:
-12.07%
1Y Performance:
+30.48%
1-Day Range:
$143.90
$148.40
1-Week Range:
$143.90
$149.94
52-Week Range:
$111.03
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
147.44 | 7.92B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Vident Advisory LLC Takes Position in Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Receives $193.60 Consensus PT from Analysts - MarketBeat
Masimo Corporation $MASI Shares Sold by Fred Alger Management LLC - MarketBeat
Masimo Renews Partnership with Royal Philips - Orange County Business Journal
BTIG Reiterates Buy Rating for Masimo (MASI) with $198 Price Tar - GuruFocus
Medical Tech Leaders Masimo and Philips Join Forces on Next-Gen AI Monitoring Solutions Through 2026 - Stock Titan
Great Lakes Advisors LLC Trims Stake in Masimo Corporation $MASI - MarketBeat
Gotham Asset Management LLC Increases Position in Masimo Corporation $MASI - MarketBeat
Alliancebernstein L.P. Trims Position in Masimo Corporation $MASI - MarketBeat
Advisors Asset Management Inc. Acquires 4,314 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Corporation $MASI Position Increased by Baird Financial Group Inc. - MarketBeat
U.S. Customs asks for Masimo lawsuit to be dismissed in the company’s ongoing legal battle with Apple - MacTech.com
Redmile Group LLC Purchases New Shares in Masimo Corporation $MASI - MarketBeat
Masimo Corporation $MASI Shares Purchased by Alyeska Investment Group L.P. - MarketBeat
4D Advisors LLC Makes New Investment in Masimo Corporation $MASI - MarketBeat
Federal Agencies Push To Toss Masimo's Apple Watch Suit - Law360
US Customs Seeks Dismissal of Masimo Lawsuit Over Apple Watch Redesign - WebProNews
Apple Restores Blood Oxygen Tracking on Apple Watch After Masimo Settlement - AInvest
Apple Revives Blood Oxygen Monitoring in US After Legal Standoff with Masimo - AInvest
Alamea Verwaltungs GmbH Makes New $327,000 Investment in Masimo Corporation $MASI - MarketBeat
Apple (AAPL.US) has reached a settlement with Masimo, allowing the blood oxygen feature of the Apple Watch to return to the U.S. market. - 富途牛牛
How to integrate Masimo Corporation into portfolio analysis tools2025 Top Gainers & Smart Swing Trading Techniques - Newser
Is Masimo Corporation stock a good pick for beginnersQuarterly Trade Report & Entry Point Confirmation Signals - خودرو بانک
Using Python tools to backtest Masimo Corporation strategies2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
Will Masimo Corporation outperform during market rallies2025 Big Picture & Consistent Growth Stock Picks - khodrobank.com
Applying big data sentiment scoring on Masimo CorporationJuly 2025 Retail & Fast Entry High Yield Tips - Newser
Is Masimo Corporation stock good for income investors2025 Support & Resistance & Precise Swing Trade Alerts - خودرو بانک
News impact scoring models applied to Masimo CorporationTrade Entry Summary & Safe Entry Point Identification - Newser
Can Masimo Corporation keep up with sector leadersJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - خودرو بانک
HighTower Advisors LLC Sells 2,263 Shares of Masimo Corporation $MASI - MarketBeat
Ranking Masimo Corporation among high performing stocks via tools2025 Major Catalysts & Verified High Yield Trade Plans - Newser
US ITC tells district court it has no jurisdiction in Apple-Masimo lawsuit - BioWorld MedTech
500+ Patents Holder and Masimo Founder Joe Kiani Joins Iradimed Board to Drive MRI Tech Innovation - Stock Titan
When is the best time to exit Masimo CorporationEarnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Is Masimo Corporation in Accumulation Phase Now getLinesFromResByArray error: size == 0 - thegnnews.com
What drives Masimo Corporation’s stock price2025 Retail Activity & Consistent Income Trade Recommendations - خودرو بانک
What technical models suggest about Masimo Corporation’s comebackJuly 2025 Technicals & Fast Momentum Stock Entry Tips - Newser
Published on: 2025-08-31 20:57:16 - Newser
Statistical indicators supporting Masimo Corporation’s strength2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Published on: 2025-08-31 14:47:12 - Newser
What’s the recovery path for long term holders of Masimo CorporationJuly 2025 Price Swings & Expert Curated Trade Setups - Newser
Using portfolio simulators with Masimo Corporation includedWeekly Market Report & Weekly High Momentum Picks - Newser
Can trapped investors hope for a rebound in Masimo CorporationEarnings Risk Summary & Smart Investment Allocation Insights - Newser
Reversal indicators forming on Masimo Corporation stockExit Point & Smart Investment Allocation Insights - Newser
Rally Mode: Is Masimo Corporation showing insider buying2025 Support & Resistance & Long Hold Capital Preservation Tips - 선데이타임즈
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):